• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: RETRACTABLE TECHNOLOGIES, INC. VANISHPOINT; SYRINGE, ANTISTICK

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

RETRACTABLE TECHNOLOGIES, INC. VANISHPOINT; SYRINGE, ANTISTICK Back to Search Results
Model Number 15271
Health Effect - Clinical Code No Known Impact Or Consequence To Patient (2692)
Date of Event 07/22/2019
Type of Reportable Event Malfunction
Event or Problem Description
Safety did not engage during insulin injection.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
VANISHPOINT
Common Device Name
SYRINGE, ANTISTICK
Manufacturer (Section D)
RETRACTABLE TECHNOLOGIES, INC.
511 lobo ln
little elm TX 75068
MDR Report Key8887512
Report Number8887512
Device Sequence Number311734
Product Code MEG
UDI-Device Identifier00613703152701
UDI-Public(01)00613703152701
Combination Product (Y/N)N
Initial Reporter StateRI
Number of Events Summarized1
Summary Report (Y/N)N
Reporter Type User Facility
Initial Reporter Occupation Risk Manager
Type of Report Initial
Report Date (Section B) 07/22/2019
Report Date (Section F) 07/22/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number15271
Device Catalogue Number15271
Device Lot NumberM180501
Was the Report Sent to FDA? Yes
Event Location Hospital
Date Report to Manufacturer08/13/2019
Initial Date Received by Manufacturer Not provided
Initial Report FDA Received Date08/13/2019
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Patient Sequence Number1
Date Report Sent to FDA07/22/2019
-
-